Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
CanSinoBIO Launches its Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health
CanSinoBIO Launches its Pneumococcal Vaccine: An Innovative Choice to Safeguard Children's Health
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
CanSino Receives Another Strong Boost
CanSino Receives Another Strong Boost
CanSinoBIO Reports Outstanding H1 2024 Performance
CanSinoBIO Reports Outstanding H1 2024 Performance